The Traderszone Network

Published in TZ Latest News 21 September, 2016 by The TZ Newswire Staff

The Ratings Game: At $300,000 a year, Sarepta’s new drug is considered a steal

Eteplirsen could have been more than twice the price, an analyst said.
read more